| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytomx Therapeutics, Inc. (CTMX) have been net sellers, shedding 1,624 shares worth roughly $5K on balance.
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.42M | - | |
| Other | 650.0K | $2.25M | - | |
| CFO | 295.3K | $1.02M | - | |
| Other | 100.0K | $346.0K | - | |
| Other | 87.5K | $302.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2016 | Shannon Timothy M82 | Director | Sell | 51,343 | $10.34 | $530,810.53 | -0.6% | |
| May 24, 2016 | Shannon Timothy M82 | - | Sell | 13,253 | $10.09 | $133,735.30 | -0.1% | |
| May 24, 2016 | Canaan IX L.P. | Director, 10% Owner | Sell | 13,253 | $10.09 | $133,735.30 | -0.1% | |
| May 20, 2016 | Shannon Timothy M82 | - | Sell | 8,687 | $10.10 | $87,776.83 | - | |
| May 20, 2016 | Canaan IX L.P. | Director, 10% Owner | Sell | 8,687 | $10.10 | $87,776.83 | - | |
| Oct 14, 2015 | Gluck Frederick W | Director | Buy | 15,000 | $12.00 | $180,000.00 | +10.9% | |
| Oct 14, 2015 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Buy | 625,000 | $12.00 | $7,500,000.00 | +194.7% | |
| Oct 14, 2015 | Ladd Cynthia J | Senior VP And General Counsel | Buy | 3,000 | $12.00 | $36,000.00 | New | |
| Oct 14, 2015 | Kavanaugh William Michael | CSO, Head Res.&Non-clin. Dev. | Buy | 5,000 | $12.00 | $60,000.00 | New |